相似文献
1
Baseline hemoglobin A1c and risk of statin-induced diabetes: results of Veterans Affairs Database analysis.
BMJ Open Diabetes Res Care. 2022 Jan;10(1). doi: 10.1136/bmjdrc-2021-002554.
2
Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C.
Gastroenterology. 2011 Jan;140(1):144-52. doi: 10.1053/j.gastro.2010.08.055. Epub 2010 Sep 15.
3
[Trends in type 2 diabetes].
Rev Prat. 2010 Apr 20;60(4):461-3.
4
Evaluation of glycemic status among hypercholesterolemic patients on atorvastatin in a tertiary care hospital - A retrospective study.
Indian J Pharmacol. 2022 May-Jun;54(3):165-170. doi: 10.4103/ijp.ijp_943_20.
5
An assessment by the Statin Diabetes Safety Task Force: 2014 update.
J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S17-29. doi: 10.1016/j.jacl.2014.02.012.
6
Factors associated with treatment success in veterans with diabetes and hyperlipidemia: a retrospective study.
Diabetes Educ. 2013 Sep-Oct;39(5):664-70. doi: 10.1177/0145721713492568. Epub 2013 Jun 19.
7
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
J Am Heart Assoc. 2020 Jan 7;9(1):e014328. doi: 10.1161/JAHA.119.014328. Epub 2019 Dec 19.
8
Acute onset and worsening of diabetes concurrent with administration of statins.
Endocr J. 2005 Jun;52(3):369-72. doi: 10.1507/endocrj.52.369.
9
Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes.
J Diabetes Investig. 2016 Sep;7(5):769-76. doi: 10.1111/jdi.12483. Epub 2016 Feb 22.
10
Effect of sulfonylurea dose escalation on hemoglobin A1c in Veterans Affairs patients with type 2 diabetes.
Acta Diabetol. 2013 Apr;50(2):261-5. doi: 10.1007/s00592-010-0197-1. Epub 2010 May 29.
引用本文的文献
1
Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses.
touchREV Endocrinol. 2022 Nov;18(2):96-101. doi: 10.17925/EE.2022.18.2.96. Epub 2022 Nov 29.
本文引用的文献
1
Navigating the Wild West of Medication Adherence Reporting in Specialty Pharmacy.
J Manag Care Spec Pharm. 2019 Oct;25(10):1073-1077. doi: 10.18553/jmcp.2019.25.10.1073.
2
The diabetogenic action of statins - mechanisms and clinical implications.
Nat Rev Endocrinol. 2016 Feb;12(2):99-110. doi: 10.1038/nrendo.2015.194. Epub 2015 Dec 15.
3
A1C level and future risk of diabetes: a systematic review.
Diabetes Care. 2010 Jul;33(7):1665-73. doi: 10.2337/dc09-1939.
4
Statin therapy and risk of developing type 2 diabetes: a meta-analysis.
Diabetes Care. 2009 Oct;32(10):1924-9. doi: 10.2337/dc09-0738.
5
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
6
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0.
Zotero 插件